Invest in

Fighting Fat


Losing Weight – By Any Means Necessary

More than one-third of the US population is now officially obese (a body-mass index over 30) – a ratio that has tripled since 1960.[1] Meanwhile, the number of morbidly obese people has risen 350% in the past 3 decades.[5] Obesity contributes to many of the country’s serious health issues, from coronary disease, to diabetes to cancer, which results in close to 112,000 preventable deaths[2] while eating up 21% of US medical spending each year.[3] As big as US citizens are getting, the roster of companies joining the fight against obesity is also growing, with one weight-loss drug, Qysmia, expected to reach $2 billion in annual sales by 2017.[4] Whether companies are selling pharmaceuticals, surgeries or diet plans, fighting fat is literally big business. See More
Invest in Thematic Portfolios
Create your own customizable basket of up to 30 stocks or ETFs for as low as $9.95.
Join over 100,000 Motif customers customizing, building, and sharing motifs.
Portfolio Index 1 YR Return
Open a Motif account to view and trade this thematic portfolio
Weight Segment & Stocks Symbol 1 YR Return
44.7% Diabetes Care 13.6%
15.3% Merck & Company Inc. (new) MRK 22.5%
12.3% 8xxx 8xxxxxx 8xx 8xx 88.8%
10.9% 8xxxxx 8xx 88.8%
2.9% 8xxxxxx 8xxxxxxx 8xxxxxxxxxx 8xxx 88.8%
2.8% 8xxxxxxxxxx 8xx 8xx 8xx 88.8%
0.6% 8xxxxxxx 8xx 8xxx 88.8%
41.0% Weight Management 24.0%
15.3% MEDIFAST INC MED 47.8%
14.4% NutriSystem Inc NTRI 19.8%
8.3% 8xxxxx 8xxxxxxx 8xxxxxxxxxxxx 8xx 8x 88.8%
1.9% 8x 8xxx 8xxxxxxxxxx 8xxx 8xx 8xx 88.8%
0.8% 8xxxx 8xxxxx 8xxxxxxx 8xxx 8xxx 88.8%
0.3% 8xxxxxx 8xxxxx 8xx 8xx 88.8%
0.1% 8xx 8xxxxxxx 8xxx 8xxxx 8 8xx 88.8%
14.3% Weight Loss Drugs 21.7%
14.3% 8xxxx 8xxxxxxxxxxxxxx 8xxx 8xxx 88.8%
Quotes delayed 15 mins. Currently Sep 20, 2019 7:02:15 PM. Fields are marked with -- when data is unavailable.